Home Other Building Blocks 39262-14-1
39262-14-1,MFCD07772261
Catalog No.:AA00BYDF

39262-14-1 | Ginsenoside CK

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥95%
in stock  
$70.00   $49.00
- +
10mg
≥95%
in stock  
$118.00   $82.00
- +
25mg
≥95%
in stock  
$256.00   $179.00
- +
50mg
≥95%
in stock  
$443.00   $310.00
- +
1000mg
98% by HPLC
in stock  
$7,126.00   $4,988.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00BYDF
Chemical Name:
Ginsenoside CK
CAS Number:
39262-14-1
Molecular Formula:
C36H62O8
Molecular Weight:
622.8727
MDL Number:
MFCD07772261
SMILES:
OC[C@H]1O[C@@H](O[C@]([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@@]3(C)CC[C@@H]3[C@]2(C)CC[C@@H](C3(C)C)O)C)(CCC=C(C)C)C)[C@@H]([C@H]([C@@H]1O)O)O
Properties
Computed Properties
 
Complexity:
1070  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
15  
Heavy Atom Count:
44  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
6  
Rotatable Bond Count:
7  
XLogP3:
5.6  

Literature

Title: Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype.

Journal: Chemico-biological interactions 20180301

Title: Production of bioactive ginsenoside compound K in metabolically engineered yeast.

Journal: Cell research 20140601

Title: Absorption mechanism of ginsenoside compound K and its butyl and octyl ester prodrugs in Caco-2 cells.

Journal: Journal of agricultural and food chemistry 20121017

Title: Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801

Title: Ginsenoside compound K, not Rb1, possesses potential chemopreventive activities in human colorectal cancer.

Journal: International journal of oncology 20120601

Title: Compound K, a novel ginsenoside metabolite, inhibits adipocyte differentiation in 3T3-L1 cells: involvement of angiogenesis and MMPs.

Journal: Biochemical and biophysical research communications 20120601

Title: Enzymatic biotransformation of ginsenoside Rb1 to compound K by recombinant β-glucosidase from Microbacterium esteraromaticum.

Journal: Journal of agricultural and food chemistry 20120411

Title: Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice.

Journal: The Journal of pharmacology and experimental therapeutics 20120401

Title: Co-transformation of Panax major ginsenosides Rb₁ and Rg₁ to minor ginsenosides C-K and F₁ by Cladosporium cladosporioides.

Journal: Journal of industrial microbiology & biotechnology 20120401

Title: Intestinal metabolite compound K of panaxoside inhibits the growth of gastric carcinoma by augmenting apoptosis via Bid-mediated mitochondrial pathway.

Journal: Journal of cellular and molecular medicine 20120101

Title: Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.

Journal: Fitoterapia 20120101

Title: Snailase preparation of ginsenoside M1 from protopanaxadiol-type ginsenoside and their protective effects against CCl4-induced chronic hepatotoxicity in mice.

Journal: Molecules (Basel, Switzerland) 20111206

Title: Ginsenoside metabolite compound K differentially antagonizing tumor necrosis factor-α-induced monocyte-endothelial trafficking.

Journal: Chemico-biological interactions 20111015

Title: Subchronic toxicity studies with ginsenoside compound K delivered to dogs via intravenous administration.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110801

Title: Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.

Journal: Biochemical pharmacology 20110801

Title: Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20110601

Title: Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway.

Journal: Life sciences 20110411

Title: Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-κB p65 and reduction of matrix metalloproteinase-2/9.

Journal: Planta medica 20110301

Title: Compound K increases type I procollagen level and decreases matrix metalloproteinase-1 activity and level in ultraviolet-A-irradiated fibroblasts.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi 20110301

Title: Production of aglycon protopanaxadiol via compound K by a thermostable β-glycosidase from Pyrococcus furiosus.

Journal: Applied microbiology and biotechnology 20110201

Title: Post-exposure treatment with ginsenoside compound K ameliorates auditory functional injury associated with noise-induced hearing loss in mice.

Journal: Neuroscience letters 20110107

Title: Compound K, a metabolite of ginsenosides, facilitates spontaneous GABA release onto CA3 pyramidal neurons.

Journal: Journal of neurochemistry 20100801

Title: Effect and mechanism of ginsenosides CK and Rg1 on stimulation of glucose uptake in 3T3-L1 adipocytes.

Journal: Journal of agricultural and food chemistry 20100526

Title: Isatis tinctoria L. combined with co-stimulatory molecules blockade prolongs survival of cardiac allografts in alloantigen-primed mice.

Journal: Transplant immunology 20100501

Title: Compound K inhibits basic fibroblast growth factor-induced angiogenesis via regulation of p38 mitogen activated protein kinase and AKT in human umbilical vein endothelial cells.

Journal: Biological & pharmaceutical bulletin 20100101

Title: Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells.

Journal: International journal of molecular sciences 20100101

Title: Compound K induces apoptosis via CAMK-IV/AMPK pathways in HT-29 colon cancer cells.

Journal: Journal of agricultural and food chemistry 20091125

Title: Glucocorticoid receptor agonist compound K regulates Dectin-1-dependent inflammatory signaling through inhibition of reactive oxygen species.

Journal: Life sciences 20091021

Title: Effect of compound K, a metabolite of ginseng saponin, combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo.

Journal: Journal of agricultural and food chemistry 20090708

Title: Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells.

Journal: Journal of agricultural and food chemistry 20090225

Title: Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells.

Journal: BMC cancer 20090101

Title: Compound K suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair in human keratinocytes.

Journal: Archives of pharmacal research 20081101

Title: The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock.

Journal: Journal of cellular and molecular medicine 20080901

Title: Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1.

Journal: Journal of separation science 20080401

Title: Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229.

Journal: Journal of applied microbiology 20080301

Title: A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells.

Journal: Oncology reports 20080301

Title: Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.

Journal: Journal of agricultural and food chemistry 20071226

Title: Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng.

Journal: Journal of agricultural and food chemistry 20071114

Title: Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice.

Journal: Biological & pharmaceutical bulletin 20071101

Title: Marked production of ginsenosides Rd, F2, Rg3, and compound K by enzymatic method.

Journal: Chemical & pharmaceutical bulletin 20071001

Title: [Advances in the study of ginsenoside compound K].

Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20070901

Title: Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells.

Journal: Neuroscience letters 20070621

Title: Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.

Journal: Cardiovascular research 20070401

Title: Effect of ginsenosides on glucose uptake in human Caco-2 cells is mediated through altered Na+/glucose cotransporter 1 expression.

Journal: Journal of agricultural and food chemistry 20070307

Title: Purification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type I.

Journal: Chemical & pharmaceutical bulletin 20070201

Title: A ginsenoside metabolite, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, triggers apoptosis in activated rat hepatic stellate cells via caspase-3 activation.

Journal: Planta medica 20061001

Title: Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells.

Journal: International journal of cancer 20060115

Title: Pharmacokinetics of a ginseng saponin metabolite compound K in rats.

Journal: Biopharmaceutics & drug disposition 20060101

Title: Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.

Journal: Liver international : official journal of the International Association for the Study of the Liver 20051001

Title: Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models.

Journal: Journal of pharmacological sciences 20050901

Title: Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis.

Journal: International immunopharmacology 20050701

Title: [Determination of ginsenoside compound-K by reversed-phase high performance liquid chromatography].

Journal: Se pu = Chinese journal of chromatography 20050501

Title: Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide.

Journal: Biological & pharmaceutical bulletin 20050401

Title: Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora.

Journal: Biological & pharmaceutical bulletin 20041001

Title: Compound K induces expression of hyaluronan synthase 2 gene in transformed human keratinocytes and increases hyaluronan in hairless mouse skin.

Journal: Biochemical and biophysical research communications 20040402

Title: Differential effect of ginsenoside metabolites on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.

Journal: Molecules and cells 20040227

Title: A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.

Journal: International journal of oncology 20031001

Title: Differential effect of bovine serum albumin on ginsenoside metabolite-induced inhibition of alpha3beta4 nicotinic acetylcholine receptor expressed in Xenopus oocytes.

Journal: Archives of pharmacal research 20031001

Title: Degradation of ginsenosides in humans after oral administration.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20030801

Title: Inhibition of intracerebroventricular injection stress-induced plasma corticosterone levels by intracerebroventricularly administered compound K, a ginseng saponin metabolite, in mice.

Journal: Biological & pharmaceutical bulletin 20030701

Title: Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis.

Journal: Reproductive toxicology (Elmsford, N.Y.) 20020101

Title: The antimetastatic and immunomodulating activities of ginseng minor glycosides.

Journal: Doklady. Biochemistry and biophysics 20010101

Title: Kim JH, et al. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responsesand diseases. J Ginseng Res. 2017 Oct;41(4):435-443.

Title: Liu Y, et al. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol Sci. 2006 Jun;91(2):356-64.

Title: Zhang J, et al. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium-Induced Colitis. Drug Metab Dispos. 2015 Aug;43(8):1181-9.

Title: Liu KK, et al. Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis. Acta Pharmacol Sin. 2014 May;35(5):599-612.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:39262-14-1 Molecular Formula|39262-14-1 MDL|39262-14-1 SMILES|39262-14-1 Ginsenoside CK